...
首页> 外文期刊>Proceedings of the Latvian Academy of Sciences, Section B. Natural, exact, and applied sciences, B dala. Dabaszinatnes >Heart rate and other risk factors in outpatients with stable coronary artery disease in Latvia
【24h】

Heart rate and other risk factors in outpatients with stable coronary artery disease in Latvia

机译:拉脱维亚稳定冠心病门诊患者的心率和其他危险因素

获取原文

摘要

Heart rate and other risk factors in outpatients with stable coronary artery disease in LatviaThe aim of the study was to characterise coronary artery disease (CAD) outpatients in Latvia by risk factors (RF) including heart rate (HR), physical examination data, clinical data and treatment. Twelve practitioners had each examined and questioned 6 to 12 patients with established CAD (n = 120). The most frequent cardiovascular (CV) RF and co-morbidity were dyslipidemia (94.2%) and hypertension (78.3%), respectively. Prevalence of increased resting HR (≥70 bpm) was 35.9% and 33.6%, when measured by pulse palpation and electrocardiography, respectively. Regarding other RFs, prevalence of treated but insufficiently controlled blood pressure 140/90 mmHg, total cholesterol 1 > 5 mmol/l and triglycerides > 1.7 mmol/l was 25.8%, 30.1% and 33.3%, respectively. Aspirin, statins and angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers were used in 96.7%, 94.2% and 85.0% of cases, respectively. Beta blockers were used in 81.7% of cases. Average daily doses of most frequently used β blockers (metoprolol and bisoprolol) were 32% and 53% from target doses, respectively. In three cases β blockers were combined with ivabradin. Our results suggest that practitioners follow guidelines and consider CV prevention by treating CAD patients. Our data identified, however, unused potential for better control of increased HR by higher doses and combinations of HR-reducing agents.
机译:拉脱维亚冠心病稳定的门诊患者的心率和其他危险因素研究的目的是通过风险因素(RF)来表征拉脱维亚冠心病(CAD)门诊病人的特征,包括心率(HR),体格检查数据,临床数据和治疗。十二名从业人员分别检查并询问了6至12例已建立CAD的患者(n = 120)。最常见的心血管(CV)RF和合并症分别是血脂异常(94.2%)和高血压(78.3%)。通过脉搏触诊和心电图测量,静息HR升高(≥70 bpm)的患病率分别为35.9%和33.6%。关于其他RF,已治疗但控制不佳的血压140/90 mmHg,总胆固醇1> 5 mmol / l和甘油三酸酯> 1.7 mmol / l的患病率分别为25.8%,30.1%和33.3%。阿司匹林,他汀类药物和血管紧张素转化酶抑制剂或血管紧张素受体阻滞剂分别占96.7%,94.2%和85.0%。 Beta阻滞剂用于81.7%的病例。最常用的β受体阻滞剂(美托洛尔和比索洛尔)的日均剂量分别比目标剂量高32%和53%。在三例中,β受体阻滞剂与伊伐布雷定合用。我们的结果表明,从业者应遵循准则,并考虑通过治疗CAD患者来预防CV。然而,我们的数据确定了通过更高剂量和降低HR的药物更好地控制HR增加的潜力。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号